[2] Bi J*, Tian Z*. NK cell dysfunction and checkpoint immunotherapy. Frontiers in immunology 2019, 10: 1999. [3] Bi J, Zhang Q, Liang D, Xiong L, Wei H, Sun R*, Tian Z*. T-cell Ig and ITIM domain regu...
[1] Bi J*, Tian Z*. NK Cell Exhaustion. Frontiers in immunology 2017, 8: 760.[2] Bi J*, Tian Z*. NK cell dysfunction and checkpoint immunotherapy. Frontiers in immunology 2019, 10: 1999.[3] Bi J, Zhang Q, Liang D, Xiong L, Wei H, Sun R*, Tian Z*. T-cell Ig and ITIM...
3.Devillier, Raynier, Anne-Sophie Chrétien, Thomas Pagliardini, Nassim Salem, Didier Blaise and Daniel Olive. "Mechanisms of Nk Cell Dysfunction in the Tumor Microenvironment and Current Clinical Approaches to Harness Nk Cell Potential for...
[2] Bi J*, Tian Z*. NK cell dysfunction and checkpoint immunotherapy. Frontiers in immunology 2019, 10: 1999. [3] Bi J, Zhang Q, Liang D, Xiong L, Wei H, Sun R*, Tian Z*. T-cell Ig and ITIM domain regulates natural killer cell activation in murine acute viral hepatitis. Hepato...
10月3日，山东大学齐鲁医院研究人员在期刊《Cell Reports》上发表题为“Lipid accumulation-mediated histone hypoacetylation drives persistent NK cell dysfunction in anti-tumor immunity”的研究论文，研究结果揭示了高脂血症环境中NK细胞的持续功能障碍，并将改造的NK细胞作为肿瘤免疫治疗的一种有前景的策略加以扩展。
5. Bi, J. and Z. Tian, NK Cell Dysfunction and CheckpointImmunotherapy. Front Immunol, 2019. 10:p. 1999. 6. Zitvogel, L. and G.Kroemer, Targeting PD-1/PD-L1interactions for cancer immunotherapy. Oncoimmunology, 2012. 1(8): p. 1223-1225. ...
(2019). Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells. Frontiers in Immunology, 10. [4]Weil, Sandra.Investigation of a NKG2D-dependent tumor immune escape mechanism of head and neck squamous...
[3]Carlsten, M., & Järås, M. (2019). Natural Killer Cells in Myeloid Malignancies: Immune Surveillance, NK Cell Dysfunction, and Pharmacological Opportunities to Bolster the Endogenous NK Cells. Frontiers in Immunology, 10. [4]Weil, Sandra.Investigation of a NKG2D-dependent tumor immune ...
5. Bi, J. and Z. Tian, NK Cell Dysfunction and CheckpointImmunotherapy. Front Immunol, 2019. 10:p. 1999. 6. Zitvogel, L. and G.Kroemer, Targeting PD-1/PD-L1interactions for cancer immunotherapy. Oncoimmunology, 2012. 1(8): p. 1223-1225. ...
中国科学家在行业期刊《细胞和分子免疫学》上发表了题为NK cell dysfunction in patients with COVID-19(COVID-19 患者的 NK 细胞功能障碍)的综述报告。 该研究报告称:相当一部分因感染冠状病毒病 (COVID-19) 的患者在感染后期可能会出现严重肺炎和纤维化肺损伤。有效的抗病毒免疫和预防纤维化进展对于控制 COVID...